- Title:
Change of Auditor - Time:
15:45:07 - Date:
25 May 2021 - Category:
Corporate updates - ID:
7797Z
BIOPHARMA CREDIT PLC
(THE "COMPANY")
Change of Auditor
The Company announces that, following the completion of a formal and competitive selection process, the Board has approved that Ernst & Young should be the statutory auditor of the Company for the year ending 31 December 2021.
Shareholder approval of the appointment of Ernst & Young as auditor will be sought at the 2021 Annual General Meeting on 17 June 2021.
The Board would like to thank PricewaterhouseCoopers LLP for its service to the Company.
25 May 2021
LEI: 213800AV55PYXAS7SY24
Change of Auditor 15:45:0725 May 2021Corporate updates7797Z